By taking advantage of a panel of CD8+ Ag-specific (Melan-A+ or gp100+) T-cell clones isolated from the peripheral blood of melanoma patients, we recently reported that the inhibitory effect of PD1 is associated with the co-expression of CD28 [23, 26, 27], consistent with earlier studies [18]. Here, CD28 is linked to melanoma.